0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch china biosimilar monoclonal antibodies industry 2016 market research report.Your search for "" gave back 1533495 results.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. The “Trastuzumab...
Catalog:
LPI
February 2023
Price: USD 3,660.00
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 Summary T...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
The global Biosimilars & Follow-on-Biologics market is projected to reach US$ 52070 million in 2029, increasing from US$ 22490 million in 2022,...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Biosimilars & Follow-on-biologics Industry Forecast” looks at past sales and reviews total world Biosimilars & Follow-on-biologics sales...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. Highlights The global...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global active pharmaceutical ingredient market is expected to reach approximately $175 billion by 2020, growing at a CAGR of around 6% during...
Catalog:
IQ4I
November 2014
Price: USD 4,500.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Biosimilars & Follow-on-Biologics market was valued at US$ 22490 million in 2023 and is anticipated to reach US$ 52070 million by 2030...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Recombinant Glycosylated Proteins Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR...
Catalog:
GIR
March 2023
Price: USD 4,480.00
The global Biosimilars Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
March 2023
Price: USD 3,660.00
